4//SEC Filing
NEUGEBOREN EDWARD 4
Accession 0001140361-26-000967
CIK 0001444192other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:01 PM ET
Size
5.3 KB
Accession
0001140361-26-000967
Insider Transaction Report
Form 4
NEUGEBOREN EDWARD
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-08+10,000→ 10,000 totalExercise: $3.80Exp: 2036-01-08→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date.
Signature
/s/ Robert DelAversano as attorney-in-fact for Edward Neugeboren|2026-01-12
Documents
Issuer
Grace Therapeutics, Inc.
CIK 0001444192
Entity typeother
Related Parties
1- filerCIK 0001320873
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:01 PM ET
- Size
- 5.3 KB